KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Moss Genomics, Inc. ( ($TSE:MOSS) ) has issued an announcement. Moss Genomics Inc. has mined its first Bitcoin Cash (BCH) block using proprietary ...

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

As of February 3, 2023, the average one-year price target for 10x Genomics, Inc. is $50.80. The forecasts range from a low of $25.25 to a high of $68.25. The average price target represents an ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Contextual Genomics Inc., a leading cancer genomics company, is pleased to announce that it has signed a contribution agreement with the National Research ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks. On December 15, 2025, ...

We recently compiled a list of the 10 Stocks That Will Skyrocket. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks. The primary ...

10x Genomics Inc. Annual cash flow by MarketWatch. View TXG net cash flow, operating cash flow, operating expenses and cash dividends.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

Singular Genomics Systems, Inc. has announced a definitive merger agreement in which an affiliate of Deerfield Management Company will acquire the company for $20.00 per share, a 254% premium over its ...

Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") has announced it has mined a block on the Bitcoin ...